Tezepelumab helps severe asthma patients reduce oral steroids over 28 weeks
New results from the Phase III SUNRISE clinical trial show that tezepelumab significantly reduced the need for long-term oral corticosteroid use in adults with severe oral corticosteroid-dependent asthma ...
30 May 18:00 · Medical Xpress
Tezepelumab reduces steroid dependence in severe asthma patients
New results from the Phase 3 SUNRISE clinical trial show that tezepelumab significantly reduced the need for long-term oral corticosteroid use in adults with severe oral corticosteroid-dependent asthma while maintaining asthma control and improving key clinical outcomes.
29 May 02:05 · News-Medical
Tezepelumab reduces asthma exacerbations in diverse patient population
The drug tezepelumab was shown to significantly reduce exacerbations in people with severe asthma in clinical trials.
18 May 18:50 · News-Medical
last updated on 30 May 19:42